JPRN-UMIN000007575
Completed
Phase 1
Positron emission tomography using a newly-developed PET probe: [18F] Fluoroacetate (FACE) - human volunteer study - - FACE volunteer study
Shiga Medical Center Research Institute0 sites4 target enrollmentApril 1, 2012
Conditionshealthy volunteer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- healthy volunteer
- Sponsor
- Shiga Medical Center Research Institute
- Enrollment
- 4
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Annals of Nuclear Medicine Ann Nucl Med (2014) 28:371-380 Assessment of [18F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a person with a disease (diseases)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast CancerAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaNCT06502691University of Washington22
Terminated
Phase 1
18F- Fluorothymidine to Evaluate Treatment Response in LymphomaLymphomaNCT00775268National Cancer Institute (NCI)31
Active, not recruiting
Phase 2
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast CancerBreast CarcinomaNCT05226663M.D. Anderson Cancer Center36
Withdrawn
Not Applicable
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBMAstrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma MultiformeNCT00943462Centre hospitalier de l'Université de Montréal (CHUM)
Terminated
Phase 2
[18F]Fluciclatide PET Imaging of Pazopanib ResponseKidney NeoplasmNCT01961583Asan Medical Center12